Mumbai, May 29 : The BSE Sensex zooms up 882.40 points or 1.75 pc to settle at 51,422.88 in a week under review as encouraging quarterly earnings and positive global cues boosted investors sentiment.The moderation…
Mumbai, May 28 : In line with the vision of creating an end-to-end electric vehicle ecosystem in India, MG Motor India has now joined hands with Attero.The partnership is aimed at reusing and recycling the…
Mumbai, May 28 : Ashoka Buildcon has received Letter of Acceptance from FAHI DHIRIULHUN CORPORATION, a State-owned company of the Government of the Republic of the Maldives, for the Project viz. 'Design and Construction of…
PUNE, India, May 28, 2021 /PRNewswire/ -- Phoenix Group, a diverse group of companies with expertise in software, robotics & automation Products/solutions, announced the acquisition of Bit Mapper Integration Technologies (BMIT) Pune, Maharashtra. The company…
Mumbai, May 28 : Pharma Major,Zydus Cadila Today said it has introduced a new feature in the packaging of its critical drugs to help patients ensure that the product is not fake or counterfeited.The company…
Mumbai, May 28 : Pharma Major, Sun Pharma had earler announced about the Distribution Services Agreement entered into between AstraZeneca Pharma India Limited and Sun Pharma Laboratories its wholly owned subsidiary for the distribution of…
Mumbai, May 28 : HDFC Bank, under Parivartan, on Friday announced a slew of measures to set up and enhance medical infrastructure across the country to assist the fight against the pandemic. The measures comprise…
Mumbai, May 27 : Pharma major Lupin Today announced the achievement of key milestones for Lupin’s MEK inhibitor compound (LNP3794) that is planned for development by Boehringer Ingelheim in combination as potential targeted therapy for…
Mumbai, May 27 : Pharma major Zydus Cadila Today said that its biological therapy ZRC-3308, a cocktail of two SARS-CoV-2-neutralizing monoclonal antibodies (mAbs) can emerge as one of the main treatments for mild COVID-19.SARS-CoV-2 spike…
Hyderabad, May 27 :BDR Pharmaceutical Today launched BDPARIB (RUCAPARIB) to treat advanced ovarian and prostate cancers in India.BDPARIB is the first affordable generic in the India available in the form of a tablet, with the…
